Francesco Nuzzo
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.
Journal: Clinical breast cancer
Published: April 22, 2026
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941].
Journal: ESMO open
Published: December 01, 2024
CAR-T cell therapy for breast cancer: Current status and future perspective.
Journal: Cancer treatment reviews
Published: October 29, 2024
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study.
Journal: Breast (Edinburgh, Scotland)
Published: February 27, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis.
Journal: Frontiers in oncology
Published: December 28, 2023
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.
Journal: Future oncology (London, England)
Published: August 22, 2023
An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients.
Journal: In vivo (Athens, Greece)
Published: May 10, 2023
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice.
Journal: Frontiers in oncology
Published: August 30, 2022
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors.
Journal: International journal of molecular sciences
Published: July 31, 2020
Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
Journal: International journal of molecular sciences
Published: July 20, 2020
Last Updated: 09/26/2026